evodiamine has been researched along with Benign Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Lei, F; Li, J; Li, R; Liang, Z; Shi, T; Wang, S; Wang, Y; Wang, Z; Zhang, H | 1 |
| Biswal, BK; Panda, M; Tripathi, SK; Zengin, G | 1 |
| Han, BW; Hong, S; Hyun, SY; Le, HT; Lee, HY; Lim, Y; Min, HY; Nguyen, YTK; Pei, H; Song, I | 1 |
| Chen, S; Dong, G; Huang, Y; Liu, D; Ma, Z; Sheng, C; Wan, K; Zhu, F | 1 |
| Chu, C; Hu, X; Hua, H; Jia, Y; Li, D; Li, X; Wang, X; Xu, F | 1 |
| Dhulap, S; Gavaraskar, K; Hirwani, RR | 1 |
| Hu, C; Jiang, J | 1 |
4 review(s) available for evodiamine and Benign Neoplasms
| Article | Year |
|---|---|
Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers.
Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Neoplasms; Plant Extracts | 2023 |
Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Cell Proliferation; Humans; Neoplasms; Quinazolines | 2018 |
Therapeutic and cosmetic applications of Evodiamine and its derivatives--A patent review.
Topics: Alkaloids; Animals; Autoimmune Diseases; Cell Line, Tumor; Central Nervous System Diseases; Cosmetics; Evodia; Fruit; Humans; Inflammation; Metabolic Diseases; Molecular Structure; Neoplasms; Patents as Topic; Quinazolines | 2015 |
Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Evodia; Humans; Medicine, Chinese Traditional; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Quinazolines | 2009 |
3 other study(ies) available for evodiamine and Benign Neoplasms
| Article | Year |
|---|---|
Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Molecular Structure; Neoplasms; Quinazolines; Structure-Activity Relationship | 2022 |
Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Cell Proliferation; HCT116 Cells; HSP70 Heat-Shock Proteins; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Neoplasms; Neoplastic Stem Cells; Quinazolines; Signal Transduction; Transcription, Genetic; Up-Regulation | 2021 |
Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbolines; Cell Proliferation; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Male; Mice, Nude; Molecular Structure; Neoplasms; Proof of Concept Study; Quinazolines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Xenograft Model Antitumor Assays | 2021 |